Form 4 holding
Chief Executive Officer, Director
Sarepta Therapeutics, Inc.
- Security class
- Common Stock
- Shares / value
- 756,104
- Estimated value
- $13,587,188
- Report date
- 28 Jul 2026
- Price
- $17.97
- Ownership
- Direct
Michael Severino - Chief Executive Officer, Director at Sarepta Therapeutics, Inc.
Issuer-level insider activity
- Role
- Chief Executive Officer, Director
- Issuer ticker
- SRPT on Nasdaq
- Entity type
- Individual
- Source filing history
- Open source filing history
Identity
Names, identifiers, and filing context for this profile.
1 identity field
Source evidence
Original filing metadata and source links for verification.
1 source field
No buys or sells have been reported by Michael Severino since 19 Aug 2025
Reported holdings for Michael Severino in Sarepta Therapeutics, Inc.
Form 4 holding
Chief Executive Officer, Director
Sarepta Therapeutics, Inc.
- Security class
- Stock Options (right to buy)
- Shares / value
- 2,224,342
- Estimated value
- Report date
- 28 Jul 2026
- Price
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
Transaction history for Michael Severino in Sarepta Therapeutics, Inc.
| Sym | Class | Transaction | % | SEC-reported value | SEC-reported price | Shares | Shares after | Date | Ownership |
|---|
* marks a reported price that did not pass the local price check.